Kyrgyzstan

  • Results
  • /
  • Europe & the CIS
  • /
  • Kyrgyzstan

KEY RESULTS - HIV & TB

 

Treatment success rate for all new cases of TB (2015)

Source: World Health Organization

980,000 counselling and testing encounters for HIV

Source: UNDP

Retention on ART 12 months after commencing treatment (2016)

Source: UNAIDS

TB case detection rate

Source: World Health Organization

Maternal and infant mortality

Source: World Health Organization

Project Summary

UNDP has managed Global Fund HIV and TB grants in Kyrgyzstan since 2012 and 2011 respectively. The HIV grant focused on preventing HIV by promoting human rights, gender, good governance, and mainstreaming HIV/AIDS, whilst the TB programme supported the consolidation and expansion of Directly Observed Treatment, Short-course (DOTS), with a focus on drug resistant forms of TB. In 2016 UNDP became PR for the joint HIV/TB programme, the overall goal of which is to reduce the HIV and TB burden by providing universal access to TB diagnosis and treatment; using evidence based HIV prevention programmes (primarily to key populations); and providing treatment care and support to people living with HIV. Through the malaria grant (active between 2011 and 2015), UNDP implemented preventive activities including distribution of protective nets among vulnerable populations and treatment of houses with IRS. No local transmission of malaria occurred in Kyrgyzstan between 2011 and 2013. The country awaits official WHO malaria-free certification.

Formal capacity development plans are in place in Kyrgyzstan to enable transition to national delivery (expected in 2016)

PORTFOLIO OVERVIEW

 

Disease Component

HIV/ TB

Grant

KGZ-C-UNDP

Phase

Period 2 (Jul 2016 - Jun 2018)

Amount

                       $18,617,455

Rating

 

Overall Grant Rating 

 

 

  Exceeding expectations

 

  Meeting expectations

 

  Adequate

 

  Inadequate but potential demonstrated

 

  Unacceptable

 

  No rating available